Biotech

All Articles

BioAge eyes $180M from IPO, personal placement for being overweight trials

.BioAge Labs is actually checking out about $180 million in initial profits from an IPO and also an ...

Merck's LAG-3 combo falls short colorectal cancer cells phase 3 research study

.An effort by Merck &amp Co. to uncover the microsatellite steady (MSS) metastatic colorectal cancer...

Spanish VC closes $200M life scientific researches fund

.Spain-based Asabys Allies has actually shut a fund of 180 million europeans ($ 200 million), money ...

BioAge generates $198M from IPO as obesity biotech joins Nasdaq

.BioAge Labs is actually introducing almost $200 thousand by means of its Nasdaq IPO this morning, a...

Acadia takes BMS vet on board as CEO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of significant leadership hirings, firings a...

Cassava pays $40M over presumably misleading Alzheimer's update

.Cassava Sciences has accepted to pay out $40 million to resolve an examination in to insurance clai...

Merck bags alternatives on Evaxion's AI-designed injection applicants

.Merck &amp Co. has gotten possibilities on 2 Evaxion Biotech vaccine prospects, paying out $3.2 tho...

Enanta's RSV antiviral crushes virus-like lots in obstacle research

.Enanta Pharmaceuticals has actually connected its own breathing syncytial infection (RSV) antiviral...

Biogen containers SAGE-324 cooperation after crucial shake neglect

.Biogen has carried out the final ceremonies to its own collaboration with Sage Therapeutics on SAGE...

AbbVie Parkinson's drug from $8.7 B Cerevel purchase ratings

.On the very same day that some Parkinson's disease drugs are actually being actually disputed, AbbV...